Infinity Pharma's IPI-926 enters phase II trial and receives FDA orphan status in chondrosarcoma March 8, 2011
Allos and FDA reach SPA agreement for phase III trial of Folotyn in peripheral T-cell lymphoma March 4, 2011
RSS